Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties; Leopold Sellner; Johannes Schetelig; Linda Koster; Goda Choi; Didier Blaise; Dietrich Beelen; Fabrizio Carnevale Schianca; Jakob Passweg; Urs Schanz; Emmanuel Gyan; Federica Sora; Nicolaus Kröger; Gerald G Wulf; Gwendolyn Van Gorkom; Jiri Mayer; Corentin Orvain; Jean Henri Bourhis; Pavel Jindra; Victoria Potter; Francesco Zallio; Elisabeth Vandenberghe; Stephen Robinson; Patrick J Hayden; Ibrahim Yakoub-Agha; Silvia Montoto; Peter Dreger

doi:10.1038/s41409-020-0946-x

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties, Leopold Sellner^*, Johannes Schetelig, Linda Koster, Goda Choi, Didier Blaise, Dietrich Beelen, Fabrizio Carnevale Schianca, Jakob Passweg, Urs Schanz, Emmanuel Gyan, Federica Sora, Nicolaus Kröger, Gerald G Wulf, Gwendolyn Van Gorkom, Jiri Mayer, Corentin Orvain, Jean Henri Bourhis, Pavel Jindra, Victoria PotterFrancesco Zallio, Elisabeth Vandenberghe, Stephen Robinson, Patrick J Hayden, Ibrahim Yakoub-Agha, Silvia Montoto, Peter Dreger

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	2335-2338
Number of pages	4
Journal	Bone marrow transplantation
Issue number	12
Early online date	2020
DOIs	https://doi.org/10.1038/s41409-020-0946-x
Publication status	Published - 22-May-2020

Keywords

RITUXIMAB
INHIBITION
OUTCOMES
TRIAL

Access to Document

10.1038/s41409-020-0946-x

Embargoed Document

Idelalisib exposure before allogeneic stem cell transplantation in
Final publisher's version, 614 KB
Request copy

Cite this

European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties, Sellner, L., Schetelig, J., Koster, L., Choi, G., Blaise, D., Beelen, D., Schianca, F. C., Passweg, J., Schanz, U., Gyan, E., Sora, F., Kröger, N., Wulf, G. G., Van Gorkom, G., Mayer, J., Orvain, C., Bourhis, J. H., Jindra, P., ... Dreger, P. (2020). Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey. Bone marrow transplantation, (12), 2335-2338. https://doi.org/10.1038/s41409-020-0946-x

European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties ; Sellner, Leopold ; Schetelig, Johannes ; Koster, Linda ; Choi, Goda ; Blaise, Didier ; Beelen, Dietrich ; Schianca, Fabrizio Carnevale ; Passweg, Jakob ; Schanz, Urs ; Gyan, Emmanuel ; Sora, Federica ; Kröger, Nicolaus ; Wulf, Gerald G ; Van Gorkom, Gwendolyn ; Mayer, Jiri ; Orvain, Corentin ; Bourhis, Jean Henri ; Jindra, Pavel ; Potter, Victoria ; Zallio, Francesco ; Vandenberghe, Elisabeth ; Robinson, Stephen ; Hayden, Patrick J ; Yakoub-Agha, Ibrahim ; Montoto, Silvia ; Dreger, Peter. / Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma : an EBMT survey. In: Bone marrow transplantation. 2020 ; No. 12. pp. 2335-2338.

@article{3c98e7a9fc9d4aa4bc1933faeb6e6946,

title = "Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey",

keywords = "RITUXIMAB, INHIBITION, OUTCOMES, TRIAL",

author = "{European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties} and Leopold Sellner and Johannes Schetelig and Linda Koster and Goda Choi and Didier Blaise and Dietrich Beelen and Schianca, {Fabrizio Carnevale} and Jakob Passweg and Urs Schanz and Emmanuel Gyan and Federica Sora and Nicolaus Kr{\"o}ger and Wulf, {Gerald G} and {Van Gorkom}, Gwendolyn and Jiri Mayer and Corentin Orvain and Bourhis, {Jean Henri} and Pavel Jindra and Victoria Potter and Francesco Zallio and Elisabeth Vandenberghe and Stephen Robinson and Hayden, {Patrick J} and Ibrahim Yakoub-Agha and Silvia Montoto and Peter Dreger",

year = "2020",

month = may,

day = "22",

doi = "10.1038/s41409-020-0946-x",

language = "English",

pages = "2335--2338",

journal = "Bone marrow transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "12",

}

European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties, Sellner, L, Schetelig, J, Koster, L, Choi, G, Blaise, D, Beelen, D, Schianca, FC, Passweg, J, Schanz, U, Gyan, E, Sora, F, Kröger, N, Wulf, GG, Van Gorkom, G, Mayer, J, Orvain, C, Bourhis, JH, Jindra, P, Potter, V, Zallio, F, Vandenberghe, E, Robinson, S, Hayden, PJ, Yakoub-Agha, I, Montoto, S & Dreger, P 2020, 'Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey', Bone marrow transplantation, no. 12, pp. 2335-2338. https://doi.org/10.1038/s41409-020-0946-x

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma : an EBMT survey. / European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties; Sellner, Leopold; Schetelig, Johannes; Koster, Linda; Choi, Goda; Blaise, Didier; Beelen, Dietrich; Schianca, Fabrizio Carnevale; Passweg, Jakob; Schanz, Urs; Gyan, Emmanuel; Sora, Federica; Kröger, Nicolaus; Wulf, Gerald G; Van Gorkom, Gwendolyn; Mayer, Jiri; Orvain, Corentin; Bourhis, Jean Henri; Jindra, Pavel; Potter, Victoria; Zallio, Francesco; Vandenberghe, Elisabeth; Robinson, Stephen; Hayden, Patrick J; Yakoub-Agha, Ibrahim; Montoto, Silvia; Dreger, Peter.

In: Bone marrow transplantation, No. 12, 22.05.2020, p. 2335-2338.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma

T2 - an EBMT survey

AU - European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties

AU - Sellner, Leopold

AU - Schetelig, Johannes

AU - Koster, Linda

AU - Choi, Goda

AU - Blaise, Didier

AU - Beelen, Dietrich

AU - Schianca, Fabrizio Carnevale

AU - Passweg, Jakob

AU - Schanz, Urs

AU - Gyan, Emmanuel

AU - Sora, Federica

AU - Kröger, Nicolaus

AU - Wulf, Gerald G

AU - Van Gorkom, Gwendolyn

AU - Mayer, Jiri

AU - Orvain, Corentin

AU - Bourhis, Jean Henri

AU - Jindra, Pavel

AU - Potter, Victoria

AU - Zallio, Francesco

AU - Vandenberghe, Elisabeth

AU - Robinson, Stephen

AU - Hayden, Patrick J

AU - Yakoub-Agha, Ibrahim

AU - Montoto, Silvia

AU - Dreger, Peter

PY - 2020/5/22

Y1 - 2020/5/22

KW - RITUXIMAB

KW - INHIBITION

KW - OUTCOMES

KW - TRIAL

U2 - 10.1038/s41409-020-0946-x

DO - 10.1038/s41409-020-0946-x

M3 - Letter

C2 - 32444863

SP - 2335

EP - 2338

JO - Bone marrow transplantation

JF - Bone marrow transplantation

SN - 0268-3369

IS - 12

ER -

European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties, Sellner L, Schetelig J, Koster L, Choi G, Blaise D et al. Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey. Bone marrow transplantation. 2020 May 22;(12):2335-2338. https://doi.org/10.1038/s41409-020-0946-x